相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting KDM4C enhances CD8+ T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer
Xiaohua Jie et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
The two sides of Hippo pathway in cancer
Fu-Long Li et al.
SEMINARS IN CANCER BIOLOGY (2022)
The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers
Dawid Dorna et al.
CELLS (2022)
SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters
Yanjun Zhang et al.
NATURE COMMUNICATIONS (2022)
Mechanistic insights into KDM4A driven genomic instability
Nicolas L. Young et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2021)
LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan
Elham Fakhr et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
The inhibitors of KDM4 and KDM6 histone lysine demethylases enhance the anti-growth effects of erlotinib and HS-173 in head and neck cancer cells
Robert Kleszcz et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
H3K36 trimethylation-mediated biological functions in cancer
Chu Xiao et al.
CLINICAL EPIGENETICS (2021)
Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress
Wuchang Zhang et al.
MOLECULAR CELL (2021)
PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1
Lucas Schneider et al.
ONCOGENESIS (2021)
Asporin represses gastric cancer apoptosis via activating LEF1-mediated gene transcription independent of β-catenin
Zheng Zhang et al.
ONCOGENE (2021)
Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway
Yi Zhang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Histone modifications in oral squamous cell carcinoma and oral potentially malignant disorders
Huamei Yang et al.
ORAL DISEASES (2020)
SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation
Vivien Freihen et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Wnt-Induced Stabilization of KDM4C Is Required for Wnt/beta-Catenin Target Gene Expression and Glioblastoma Tumorigenesis
Yaohui Chen et al.
CANCER RESEARCH (2020)
Global patterns and trends in cancers of the lip, tongue and mouth
Adalberto Miranda-Filho et al.
ORAL ONCOLOGY (2020)
The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas
Jaroslaw Paluszczak
CELLS (2020)
The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma
Yue Zhao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload
Shohei Ikeda et al.
CIRCULATION RESEARCH (2019)
Transcriptional Selectivity of Epigenetic Therapy in Cancer
Takahiro Sato et al.
CANCER RESEARCH (2017)
KDM4A as a prognostic marker of oral squamous cell carcinoma: Evidence from tissue microarray studies in a multicenter cohort
Xin Jin et al.
ONCOTARGET (2017)
microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1
Lan-xuan Huang et al.
CANCER SCIENCE (2017)
KDM4 Inhibition Targets Breast Cancer Stem-like Cells
Eric Metzger et al.
CANCER RESEARCH (2017)
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
Noa Furth et al.
CELL DEATH AND DIFFERENTIATION (2017)
Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge
Maria Noel Marzano Rodrigues Petruzzi et al.
DIAGNOSTIC PATHOLOGY (2017)
Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer
Sylvain Delaunay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Tcf1 and Lef1 pack their own HDAC
Charles P. Ng et al.
NATURE IMMUNOLOGY (2016)
SCFFbxo22-KDM4A targets methylated p53 for degradation and regulates senescence
Yoshikazu Johmura et al.
NATURE COMMUNICATIONS (2016)
KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis
Ling-Yu Wang et al.
CELL REPORTS (2016)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
A Coding Single-Nucleotide Polymorphism in Lysine Demethylase KDM4A Associates with Increased Sensitivity to mTOR Inhibitors
Capucine Van Rechem et al.
CANCER DISCOVERY (2015)
The role of the histone demethylase KDM4A in cancer
Lissania Guerra-Calderas et al.
CANCER GENETICS (2015)
Gene-Specific Methylation Control of H3K9 and H3K36 on Neurotrophic BDNF versus Astroglial GFAP Genes by KDM4A/C Regulates Neural Stem Cell Differentiation
Anna Cascante et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Expression of LEF1 is an independent prognostic factor for patients with oral squamous cell carcinoma
Min-Cheng Su et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2014)
Targeting the β-catenin nuclear transport pathway in cancer
Cara Jamieson et al.
SEMINARS IN CANCER BIOLOGY (2014)
The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells
P. Wu et al.
CELL DEATH & DISEASE (2014)
Histone Modification Patterns Correlate With Patient Outcome in Oral Squamous Cell Carcinoma
Ya-Wei Chen et al.
CANCER (2013)
The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl
N. Reuven et al.
CELL DEATH AND DIFFERENTIATION (2013)
IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)
Anne Zirkel et al.
NUCLEIC ACIDS RESEARCH (2013)
Epigenetic Activation of AP1 Promotes Squamous Cell Carcinoma Metastasis
Xiangming Ding et al.
SCIENCE SIGNALING (2013)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells
Tae-Dong Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1
P. Liu et al.
LEUKEMIA (2012)
Deciphering arginine methylation: Tudor tells the tale
Chen Chen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
The histone H3K36 demethylase Rph1/KDM4 regulates the expression of the photoreactivation gene PHR1
Chung-Yi Liang et al.
NUCLEIC ACIDS RESEARCH (2011)
LEF1 in Androgen-Independent Prostate Cancer: Regulation of Androgen Receptor Expression, Prostate Cancer Growth, and Invasion
Yirong Li et al.
CANCER RESEARCH (2009)
LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer
Yan Wang et al.
CELL (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D
Sook Shin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase
Jean-Francois Couture et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36
Robert J. Klose et al.
NATURE (2006)
β-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1)
M Asally et al.
EXPERIMENTAL CELL RESEARCH (2005)
Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein
SG Gray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2)
DZ Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
分享论文
